Diabetic Kidney Disease Treatment
in Hyderabad, India
PACE Hospitals is recognized as one of the best hospitals for diabetic kidney disease treatment in Hyderabad, Telangana, India. Our expert team of nephrologists and dietitians follows a multidisciplinary approach to diagnose and manage diabetic kidney disease (DKD), also known as diabetic nephropathy. We utilize advanced diagnostics such as blood tests, urinalysis, and imaging to monitor kidney function and detect early damage.
We create individualized treatment plans aimed at stabilizing blood sugar and blood pressure, minimizing protein leakage in urine, and delaying the progression of kidney damage. Depending on the stage of kidney involvement, we offer a combination of medications, dietary guidance, lifestyle changes, and regular follow-ups. With a strong focus on patient care, our goal is to prevent complications, enhance quality of life, and support kidney health at every stage.
Book an Appointment for
Diabetic Kidney Disease Treatment
Diabetic Kidney Disease (DKD) Treatment Online Appointment
Thank you for contacting us. We will get back to you as soon as possible. Kindly save these contact details in your contacts to receive calls and messages:-
Appointment Desk: 04048486868
WhatsApp: 8977889778
Regards,
PACE Hospitals
HITEC City and Madeenaguda
Hyderabad, Telangana, India.
Oops, there was an error sending your message. Please try again later. Kindly save these contact details in your contacts to receive calls and messages:-
Appointment Desk: 04048486868
WhatsApp: 8977889778
Regards,
PACE Hospitals
HITEC City and Madeenaguda
Hyderabad, Telangana, India.
Why Choose PACE Hospitals for Diabetic Kidney Disease Treatment?
Regular Screening and Personalized Treatment Plans to Slow Kidney Damage Progression
Top Nephrologists and Endocrinologists in Hyderabad for effective control of DKD
Equipped with 24x7 dialysis, renal function tests, ultrasound, and biopsy services
Comprehensive Lifestyle & Nutrition Support for long-term kidney health
Diabetic Kidney Disease Diagnosis
Diagnosing diabetic kidney disease (DKD) is an important step in managing diabetes, as kidney damage can develop silently and progress over time. DKD is one of the most common complications of both type 1 diabetes and type 2 diabetes and is a leading cause of chronic kidney disease worldwide. Early diagnosis helps preserve kidney function, prevent complications, and improve long-term outcomes.
The diagnostic evaluation includes the following:
- Risk Assessment
- Medical History
- Physical Examination
- Diagnostic Tests
- Staging
Risk Assessment: Risk assessment begins with identifying diabetic patients who are most likely to develop kidney disease. The likelihood increases with longer duration of diabetes, especially in individuals with poor glycemic control, hypertension, or existing cardiovascular disease.
Additional risk factors include obesity, smoking, older age, and a family history of kidney disease. People from certain populations such as those of South Asian, African, or Indigenous descent are also at greater risk. Screening for kidney damage is advised annually in all patients with type 2 diabetes and in those with type 1 diabetes starting five years after diagnosis.
Medical History: A thorough medical history helps the nephrologist assess the duration and control of diabetes and other coexisting conditions like hypertension and heart disease. Poor control of blood sugar or blood pressure over time significantly increases the likelihood of kidney damage. The patient is also asked about related complications such as diabetic retinopathy or neuropathy, which often develop in parallel with kidney involvement. Symptoms such as swelling in the feet, changes in urination (like frothy urine), fatigue, or reduced appetite may suggest progressing kidney dysfunction. Reviewing past lab results helps determine whether the damage is chronic and ongoing.
Physical Examination: The physical examination provides useful clinical clues about the presence and severity of DKD. Blood pressure measurement is a priority, as uncontrolled hypertension accelerates kidney damage. The nephrologist also checks for signs of fluid retention, such as ankle swelling or facial puffiness. Pallor may point to anemia, a common finding in moderate to advanced kidney disease. Cardiovascular signs like elevated jugular venous pressure or crackles in the lungs may suggest fluid overload. In more advanced cases, signs such as dry skin, muscle cramps, or confusion could indicate uremia, a result of severe kidney impairment.
Diagnostic Tests: The diagnosis of diabetic kidney disease (DKD) involves identifying early signs of kidney damage in individuals with diabetes. Because DKD often begins silently, these tests are critical for early detection and slowing disease progression.
Key Diagnostic Tests Include:
- Urine Albumin-to-Creatinine Ratio (ACR)
- Estimated Glomerular Filtration Rate (eGFR)
- Serum Creatinine
- Urinalysis
- Blood Glucose and HbA1c Test
- Serum Lipid Profile
- Electrolyte Panel
- Hemoglobin and Complete Blood Count (CBC)
- Kidney Ultrasound (in selected cases)
- Kidney Biopsy (only when needed)
Urine Albumin-to-Creatinine Ratio (ACR)
ACR is the most sensitive test to detect early kidney damage in people with diabetes. Even small amounts of albumin in the urine (called microalbuminuria) can signal the beginning of DKD. An ACR of ≥30 mg/g is abnormal. This test should be done at least once a year in all diabetic patients.
Estimated Glomerular Filtration Rate (eGFR)
eGFR estimates how well the kidneys are filtering waste from the blood. It is calculated from serum creatinine and helps monitor kidney function over time. A drop in eGFR below 60 mL/min/1.73 m² is consistent with moderate to severe kidney damage.
Serum Creatinine
Serum creatinine is a waste product that builds up in the blood when kidney function declines. It is used to calculate eGFR. While normal values can vary by age and muscle mass, a rising creatinine level in a diabetic patient raises concern for DKD.
Urinalysis
Basic urinalysis helps identify protein, blood, or other abnormalities in the urine. The presence of protein or red blood cell casts may suggest glomerular involvement, which is common in diabetic nephropathy. It also helps rule out infections or non-diabetic causes.
Blood Glucose and HbA1c
Since poor blood sugar control is the main cause of DKD, measuring blood glucose and glycated hemoglobin (HbA1c) is essential. High HbA1c levels indicate chronic hyperglycemia, which accelerates kidney damage. Good glycemic control is key in both diagnosis and management.
Serum Lipid Profile
People with diabetes and DKD often have abnormal cholesterol levels, which increase cardiovascular risk. A lipid profile measures total cholesterol, LDL, HDL, and triglycerides. Managing lipid levels is part of comprehensive DKD care.
Electrolyte Panel
This panel checks levels of sodium, potassium, chloride, and bicarbonate. In DKD, potassium levels may rise, and bicarbonate may fall due to metabolic acidosis. These findings indicate worsening kidney function and influence treatment adjustments.
Hemoglobin and Complete Blood Count (CBC)
Anemia is common in advanced DKD. The CBC test detects low hemoglobin, which may occur due to decreased erythropoietin production. Identifying anemia early helps manage fatigue and improve quality of life.
Kidney Ultrasound
Imaging is not routinely required in early DKD, but may be used if there's unexplained decline in kidney function or suspicion of obstruction. In DKD, kidneys may appear normal or slightly enlarged until late stages. Ultrasound also helps rule out structural issues.
Kidney Biopsy
(For selected cases only)
A biopsy is rarely needed but may be considered if the patient has rapid decline in kidney function, active urinary sediment (blood or casts), or no history of long-standing diabetes. It helps rule out non-diabetic kidney diseases that may require different treatment.
Diabetic Kidney Disease Stages
Staging helps determine how advanced kidney damage is in patients with diabetic kidney disease. It is based on how well the kidneys filter blood (eGFR) and the amount of protein lost in the urine (albuminuria). This information guides treatment decisions and long-term monitoring.
Staging of DKD is determined by two key factors: the estimated glomerular filtration rate (eGFR), which indicates how well the kidneys are filtering waste, and the urine albumin-to-creatinine ratio (ACR), which reflects the extent of protein leakage into the urine. Together, these measures help assess the severity of kidney damage, stratify risk, and guide appropriate management strategies.
Staging by eGFR
| Stage | eGFR (mL/min/1.73 m²) | Description |
|---|---|---|
| G1 | ≥ 90 | Normal or high function |
| G2 | 60–89 | Mild decrease |
| G3a | 45–59 | Mild to moderate decrease |
| G3b | 30–44 | Moderate to severe decrease |
| G4 | 15–29 | Severe decrease |
| G5 | < 15 | Kidney failure |
Staging by Albuminuria
| Category | ACR (mg/g) | Description |
|---|---|---|
| A1 | < 30 | Normal to mildly increased |
| A2 | 30–300 | Moderately increased |
| A3 | > 300 | Severely increased |
Differential Diagnosis of Diabetic Kidney Disease
Differential diagnosis refers to the process of ruling out other kidney diseases that may resemble diabetic kidney disease (DKD). Although DKD is a common complication of diabetes, not all kidney issues in diabetic individuals are due to DKD. Identifying the correct cause of kidney dysfunction is crucial to ensure proper treatment and to avoid unnecessary or inappropriate therapies.
Below are common differential diagnoses that should be considered when evaluating a patient with suspected DKD:
- Acute Kidney Injury (AKI) – A sudden and often reversible decline in kidney function, frequently caused by dehydration, infections, or nephrotoxic drugs.
- Hypertensive Nephrosclerosis – Kidney damage primarily resulting from long-standing uncontrolled hypertension, often with minimal proteinuria.
- IgA Nephropathy – A glomerular disease presenting with hematuria and sometimes proteinuria, typically in younger individuals.
- Focal Segmental Glomerulosclerosis (FSGS) – Characterized by segmental scarring in the glomeruli, leading to high levels of proteinuria, especially in the absence of diabetic retinopathy.
- Membranous Nephropathy – An immune-mediated condition causing nephrotic-range proteinuria, more likely in individuals without classic diabetic complications.
Each of these conditions presents differently and must be carefully evaluated:
Acute Kidney Injury (AKI)
AKI is characterized by a sudden decline in kidney function over hours to days, often triggered by dehydration, infections, medications, or obstruction. Unlike DKD, which develops gradually, AKI may be reversible if treated promptly. If a diabetic patient experiences a rapid drop in kidney function, AKI should be considered before diagnosing DKD.
Hypertensive Nephrosclerosis
This condition results from chronic high blood pressure, damaging the small blood vessels in the kidneys. It can occur in both diabetic and non-diabetic individuals. Differentiating it from DKD is crucial, as it often shows lower levels of proteinuria and may lack associated diabetic complications such as retinopathy.
IgA Nephropathy
IgA nephropathy involves the deposition of IgA antibodies in the kidney’s filtering units, leading to inflammation. It generally presents in blood in the urine (hematuria) and may occur in younger patients. The presence of visible hematuria or red blood cell casts in a diabetic patient should prompt consideration of IgA nephropathy as an alternative diagnosis.
Focal Segmental Glomerulosclerosis (FSGS)
FSGS causes scarring in parts of some glomeruli and is often associated with high levels of proteinuria and resistance to standard treatments. In diabetic patients with heavy proteinuria and no diabetic retinopathy, FSGS may be the true underlying disease, warranting a kidney biopsy for confirmation.
Membranous Nephropathy
This condition causes thickening of the glomerular basement membrane and presents with significant proteinuria. It can resemble DKD, but often occurs without a long history of diabetes or without other microvascular complications. It should be considered when nephrotic-range proteinuria is present without typical signs of DKD.
When the diagnosis remains unclear, a kidney biopsy becomes essential to distinguish DKD from these other possibilities and guide the most appropriate treatment.
Considerations of a Nephrologist Before Using SGLT2 Inhibitors in Diabetic Kidney Disease
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are one of the most impactful class of medications used in diabetic kidney disease. These drugs lower blood glucose by promoting its excretion in urine, and they also offer direct kidney and cardiovascular protection.
Considerations for the Use of SGLT2 Inhibitors include:
- Kidney Function: Initiation is usually recommended when eGFR is above a specific threshold (often ≥30 mL/min/1.73 m²). Below this, continuation may still be beneficial but requires careful monitoring.
- Volume Status: SGLT2 inhibitors can increase urination and lead to dehydration, especially in patients on diuretics. Dose adjustments and patient education are needed.
- Infection Risk: There is a higher risk of genital yeast infections. Patients should be informed about hygiene and early symptoms.
- Temporary Discontinuation: During acute illness or before surgery, SGLT2 inhibitors should be paused to reduce the risk of ketoacidosis.
- Cardiovascular Benefits: These medications reduce the risk of hospitalization for heart failure and are now part of standard care for DKD patients with or without overt heart disease.
The treatment of diabetic kidney disease (DKD) focuses on slowing the progression of kidney damage, managing diabetes and related complications, and preserving overall health. Because DKD is a chronic and progressive condition, early and consistent treatment is key to avoiding kidney failure and the need for dialysis or transplantation.
Treatment plan for diabetic kidney disease include:
- Lifestyle Modifications
- Blood Sugar Management
- Control of Blood Pressure
- Medications to Protect Kidney Function
- Treatment of DKD Complications
- Monitoring and Follow-Up
- Renal Replacement Therapy (Dialysis or Transplantation)
Lifestyle Modifications
Healthy lifestyle changes are the foundation of managing DKD. A kidney- and diabetes-friendly diet is essential and often includes reducing salt, limiting protein intake (in later stages), and avoiding high-phosphorus and high-potassium foods as needed. A dietitian can help patients personalize their meals while meeting nutritional needs.
Exercise helps improve blood pressure, blood sugar, and weight. Patients are encouraged to engage in moderate physical activity like walking, swimming, or cycling. Smoking cessation is critical, as tobacco use accelerates kidney and cardiovascular damage. Avoiding over-the-counter medications harmful to the kidneys, especially NSAIDs, is also advised.
Blood Sugar Management
Controlling blood glucose levels is essential to slow the progression of DKD. The goal is to maintain HbA1c within individualized target ranges, often around 7%, though this may vary based on age and comorbidities.
Newer classes of glucose-lowering drugs, such as SGLT2 inhibitors and GLP-1 receptor agonists, offer both glycemic control and kidney protection. Nephrologists and endocrinologists collaborate to adjust diabetes medications based on kidney function.
Control of Blood Pressure
Managing hypertension is critical in DKD, as high blood pressure worsens kidney function. The target blood pressure is generally below 130/80 mmHg.
First-line treatments include RAAS inhibitors (ACE inhibitors or ARBs), which reduce proteinuria and slow disease progression. In more advanced cases, additional drug classes such as calcium channel blockers, beta-blockers, or diuretics may be required to reach the target.
Medications to Protect Kidney Function
Nephrologists use several drug classes to preserve kidney function and reduce cardiovascular risk:
RAAS blockers
Reduce proteinuria and prevent glomerular damage.
SGLT2 inhibitors
Offer kidney and heart protection beyond glucose control.
Mineralocorticoid receptor antagonists
Used selectively to reduce inflammation and fibrosis.
Statins
Reduce lipid levels and lower cardiovascular risk.
Alkali therapy
Corrects metabolic acidosis in advanced DKD.
Drug dosages are adjusted according to eGFR to avoid toxicity. Nephrologists also ensure nephrotoxic medications are avoided.
Treatment of DKD Complications
Diabetic kidney disease can lead to a range of complications that require specific management:
Anemia
Managed with iron supplements and erythropoiesis-stimulating agents if needed.
Bone and mineral disorders
Treated with phosphate binders, vitamin D analogs, and PTH regulators.
Fluid overload
Controlled with low-sodium diets and diuretics.
Hyperkalemia
Managed with dietary potassium restriction and potassium-lowering therapies.
Metabolic acidosis
Treated with oral bicarbonate when bicarbonate levels are low.
Addressing these complications improves the outcomes and quality of life.
Monitoring and Follow-Up
Regular monitoring is essential to track DKD progression and adjust treatment:
Kidney function tests (eGFR and serum creatinine)
Urine ACR to track protein loss
Blood pressure
HbA1c and blood glucose
Electrolytes, hemoglobin, calcium, phosphorus, and PTH
The frequency of follow-up depends on the stage of disease. Early stages may require monitoring every 6–12 months, while later stages may need assessments every 1–3 months.
Renal Replacement Therapy (Dialysis or Transplantation)
In stage 5 DKD, when kidney function is severely impaired (eGFR <15 mL/min/1.73 m²), renal replacement therapy becomes necessary.
Hemodialysis
Blood is filtered using a machine, typically in a dialysis center.
Peritoneal dialysis
A home-based method that uses the abdominal lining to filter blood.
Kidney transplantation
The preferred option for eligible patients, offering better long-term survival and quality of life.
Planning for dialysis or transplantation should begin in stage 4. Conservative care may be an option for patients not suited for dialysis.
Patient Education and Diet Guidance in Diabetic Kidney Disease
Patient education is vital in DKD. It empowers patients to take control of their condition and make informed decisions. Education includes:
- Understanding kidney function and DKD progression
- Importance of medication adherence and regular monitoring
- Recognizing signs of complications
- Avoiding harmful substances (e.g., certain OTC drugs)
- Collaborating with a healthcare team that includes nephrologists, endocrinologists, nurses, and dietitians
Dietary guidance focuses on individual needs and may include sodium restriction, potassium and phosphorus control, and appropriate protein intake.
Frequently Asked Questions (FAQs) on Diabetic Kidney Disease (DKD) Treatment
How does diabetes cause chronic kidney disease?
Diabetes causes chronic kidney disease (CKD) by damaging the small blood vessels (glomeruli) in the kidneys due to prolonged high blood sugar levels. Over time, this leads to protein leakage in the urine (albuminuria), inflammation, and scarring of kidney tissues. The kidneys gradually lose their ability to filter waste and maintain fluid balance. Uncontrolled blood sugar accelerates this damage, especially when combined with high blood pressure, making diabetes the leading cause of CKD globally.
Can diabetes lead to kidney disease?
Yes, diabetes is the leading cause of kidney disease worldwide. High blood sugar over time damages the kidneys’ filtering units, causing protein leakage in the urine and loss of filtering capacity. This condition, called diabetic kidney disease (DKD), can progress silently for years without symptoms. Regular monitoring and early intervention are crucial to prevent or delay kidney failure in diabetic individuals. Tight control of blood sugar and blood pressure significantly reduces this risk.
Can early diabetic kidney disease be reversed?
While DKD is not usually reversible, early intervention can significantly slow its progression. With proper control of blood sugar, blood pressure, and use of kidney-protective medications, patients can preserve kidney function for many years. In some cases, albuminuria may even decrease with treatment.
What are the treatment goals for diabetic kidney disease?
The main goals are to slow kidney damage, manage diabetes and blood pressure, reduce proteinuria, and prevent or treat complications. Treatment aims to delay the need for dialysis or transplantation and improve overall quality of life. Early and ongoing intervention is key to better outcomes.
When is dialysis or transplant considered in DKD?
These are considered when kidney function falls below 15 mL/min/1.73 m² or when symptoms of kidney failure develop. Nephrologists begin planning for dialysis or transplantation in stage 4 to ensure timely preparation and better outcomes. Early planning improves survival and quality of care.
What can a diabetic with kidney disease eat?
A diabetic with kidney disease should follow a diet that supports both blood sugar control and kidney protection. This typically includes fruits and vegetables in moderation, low-sodium meals, lean proteins, and controlled carbohydrate intake. Depending on kidney function, the intake of potassium, phosphorus, and protein may need to be limited. Processed and salty foods should be avoided. A registered dietitian can provide a personalized meal plan based on the stage of kidney disease and individual needs.
Can kidney disease cause diabetes?
While kidney disease does not directly cause diabetes, there is a complex relationship between the two. Some medications used in kidney disease (such as certain immunosuppressants post-transplant) can raise blood sugar levels, potentially leading to new-onset diabetes. Also, reduced kidney function can alter glucose metabolism and insulin clearance, making blood sugar control more challenging. However, in most cases, diabetes develops independently and is a leading cause—not a result—of kidney disease.
How does diabetes cause kidney disease?
Diabetes causes kidney disease by chronically elevating blood sugar levels, which injure the blood vessels in the kidneys. This damage disrupts the kidneys’ ability to filter waste, leading to the loss of important proteins in the urine. Over time, the kidneys become inflamed and scarred, reducing their function and potentially leading to kidney failure. Consistently high blood pressure further compounds this damage. With early treatment, this progression can be significantly slowed.
How is diabetic kidney disease diagnosed?
Diabetic kidney disease is diagnosed using two key tests: the estimated glomerular filtration rate (eGFR), which checks kidney function, and the urine albumin-to-creatinine ratio (ACR), which detects protein in the urine. These tests help determine the presence and severity of kidney damage caused by diabetes. Diagnosis is confirmed if these abnormalities persist for three months or longer, as this indicates chronic rather than temporary kidney issues.
Why is albumin in the urine important for diagnosing DKD?
Albumin is a protein that normally remains in the blood. If it's found in the urine, it indicates that the kidneys are leaking protein due to damage. This is one of the earliest signs of DKD and can be detected even before symptoms appear. Persistent albuminuria is also a predictor of disease progression and cardiovascular risk.
What role does eGFR play in diagnosing diabetic kidney disease?
eGFR measures how well your kidneys are filtering waste from the blood. A sustained eGFR below 60 mL/min/1.73 m² for three months or more suggests kidney impairment. It is also used to track disease progression and determine treatment strategies at each stage.
Are imaging tests required for diagnosing DKD?
Imaging tests like kidney ultrasound are not routinely used to diagnose DKD, but may be performed to rule out other kidney problems such as obstructions or structural abnormalities. They are particularly useful when kidney size or anatomy appears abnormal or when the diagnosis is uncertain. Imaging supports the overall diagnostic process, especially in atypical presentations.
When is a kidney biopsy needed in DKD diagnosis?
A kidney biopsy is considered when the presentation is unusual, such as rapidly declining kidney function, presence of blood in the urine, or no signs of other diabetic complications. It helps distinguish DKD from other glomerular diseases. Biopsy results can influence treatment decisions, especially if a different kidney disease is found.
How often should kidney function be checked in diabetes patients?
For type 1 diabetes, screening should begin five years after diagnosis. For type 2, it should start at diagnosis. Annual tests including eGFR and ACR are recommended to monitor kidney health and catch DKD early. More frequent testing may be needed as kidney function declines.
Which medications are used to protect kidneys in DKD?
Medications include RAAS blockers (ACE inhibitors or ARBs), SGLT2 inhibitors, and statins. These drugs help control blood pressure, reduce proteinuria, and offer cardiovascular and kidney protection. Doses are adjusted based on kidney function to ensure safety and effectiveness.
What is the role of SGLT2 inhibitors in DKD treatment?
SGLT2 inhibitors are glucose-lowering drugs that also protect kidney function. They reduce albuminuria, slow the progression of kidney disease, and lower the risk of heart failure. These benefits make them a cornerstone in DKD management, even in patients with modest kidney decline.
How is blood pressure managed in DKD?
Blood pressure control is critical. The target is usually below 130/80 mmHg. RAAS blockers are the first-line treatment, and others like diuretics or calcium channel blockers may be added if needed. Controlling blood pressure reduces stress on the kidneys and slows damage.
What complications of DKD are treated alongside kidney disease?
Common complications include anemia, bone disease, metabolic acidosis, fluid retention, and high potassium. Each is managed with specific therapies such as iron supplements, phosphate binders, or bicarbonate. Managing complications helps maintain quality of life and reduce hospitalizations.
How often should DKD patients be monitored?
Monitoring depends on the stage of the disease. In early stages, every 6–12 months may be enough. In moderate to advanced stages, follow-up is more frequent (every 1–3 months) to adjust treatment and monitor for complications. Regular monitoring prevents unexpected deterioration.
